Table 2 Drug purchase rates in Spain and Norway adjusted by age and sex, including both immigrants and natives. All main anatomical and 10 most used therapeutic ATC groups

 A

Alimentary tract and metabolism

27.9 (27.8–27.9)

12.9 (12.9–13)

 B

Blood and blood forming organs

11.4 (11.4–11.5)

10.4 (10.4–10.5)

 C

Cardiovascular system

22.1 (22.0–22.2)

18.0 (17.9–18)

 D

Dermatologicals

15.6 (15.5–15.7)

12.1 (12.1–12.1)

 G

Genito-urinary system and sex hormones

6.8 (6.7–6.8)

14.6 (14.6–14.6)

 H

Systemic hormonal preparations, excluding sex hormones and insulins

8.3 (8.3–8.4)

7.2 (7.2–7.3)

 J

Antiinfectives for systemic use

32.7 (32.5–32.8)

23.7 (23.7–23.8)

 L

Antineoplastic and immunomodulating agents

1.1 (1.0–1.1)

1.4 (1.4–1.41)

 M

Musculo-skeletal system

38 (37.9–38.1)

18.5 (18.5–18.6)

 N

Nervous system

35.2 (35.14–35.4)

24.5 (24.4–24.5)

 P

Antiparasitic products, insecticides and repellents

0.8 (0.8–0.9)

1.9 (1.8–1.9)

 R

Respiratory system

33.9 (33.8–34)

23.7 (23.6–23.7)

 S

Sensory organs

15.4 (15.3–15.4)

12.1 (12.1–12.2)

 A02B

Drugs for peptic ulcer and gastro-oesophageal reflux disease

18.5 (18.4–18.5)

5.9 (5.9–5.9)

 B01A

Antithrombotic Agents

7.1 (7.1–7.1)

8.7 (8.7–8.7)

 C10A

Lipid modifying agents

9.8 (9.7–9.8)

8.3 (8.3–8.3)

 J01C

Beta-lactam antibacterials, penicillins

20.4 (20.3–20.6)

15.7 (15.7–15.8)

 J01F

Macrolides, lincosamides and streptogramins

7.3 (7.3–7.4)

6.4 (6.4–6.5)

 M01A

Antiinflammatory and antirheumatic products, non-steroids

34.3 (34.2–34.4)

17.1 (17–17.1)

 N02B

Other analgesics and antipyretics

23.5 (23.4–23.6)

6.0 (6.0–6.0)

 N05B

Anxiolytics

11.0 (11–11.1)

5.7 (5.7–5.8)

 N06A

Antidepressants

7.0 (6.9–7.0)

5.9 (5.8–5.9)

 R06A

Antihistamines for systemic use

11.2 (11.1–11.3)

10.7 (10.7–10.7)